Notify me when Mark DeLong files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | Chief Business & Strat Officer | $3,995,365 | -$146,503 | -3.5% | 09 Jun 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|